KORU Medical Systems, Inc. (KRMD)

Market Cap	167.95M
Revenue (ttm)	35.08M
Net Income (ttm)	-5.30M
Shares Out	46.14M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	303,621
Open	3.610
Previous Close	3.680
Day's Range	3.505 - 3.680
52-Week Range	1.860 - 5.050
Beta	0.43
Analysts	Strong Buy
Price Target	4.63 (+26.16%)
Earnings Date	Aug 6, 2025

About KRMD

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: KRMD
• Website: https://www.korumedical.com

Financial Performance

In 2024, KORU Medical Systems's revenue was $33.65 million, an increase of 17.98% compared to the previous year's $28.52 million. Losses were -$6.07 million, -55.85% less than in 2023.

Analyst Summary

According to 4 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price target is $4.63, which is an increase of 26.16% from the latest price.

Price Target

$4.63

(26.16% upside)

Analyst Consensus: Strong Buy